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Objective:Valve repair for aortic insufficiency requires a tailored surgical approach determined by the leaflet and
aortic disease. Over the past decade, we have developed a functional classification of AI, which guides repair
strategy and can predict outcome. In this study, we analyze our experience with a systematic approach to aortic
valve repair.
Methods: From 1996 to 2007, 264 patients underwent elective aortic valve repair for aortic insufficiency (mean
age54  16 years; 79% male). AV was tricuspid in 171 patients bicuspid in 90 and quadricuspid in 3. One
hundred fifty three patients had type I dysfunction (aortic dilatation), 134 had type II (cusp prolapse), and 40
had type III (restrictive). Thirty six percent (96/264) of the patients had more than one identified mechanism.
Results: In-hospital mortality was 1.1% (3/264). Six patients experienced early repair failure; 3 underwent re-re-
pair. Functional classification predicted the necessary repair techniques in 82-100% of patients, with adjunctive
techniques being employed in up to 35% of patients. Mid-term follow up (median [interquartile range]:
47 [29–73] months) revealed a late mortality rate of 4.2% (11/261, 10 cardiac). Five year overall survival was
95  3%. Ten patients underwent aortic valve reoperation (1 re-repair). Freedoms from recurrent Al (>2+)
and from AV reoperation at 5 years was 88  3% and 92  4% respectively and patients with type I (82 
9%; 93  5%) or II (95  5%; 94  6%) had better outcomes compared to type III (76  17%; 84  13%).
Conclusion: Aortic valve repair is an acceptable therapeutic option for patients with aortic insufficiency. This
functional classification allows a systematic approach to the repair of Al and can help to predict the surgical tech-
niques required as well as the durability of repair. Restrictive cusp motion (type III), due to fibrosis or calcifica-
tion, is an important predictor for recurrent Al following AV repair.Earn CME credits at
http://cme.ctsnetjournals.org
In recent years, there has been increasing interest in valve-
sparing surgery to treat pathology of the aortic valve and
root. Valve-sparing aortic root replacement, pioneered by
David and Feindel1 and Yacoub and coworkers,2 has stan-
dardized the treatment of aortic root pathology and helped
to lay the foundation for the application of repair techniques
to the aortic valve. Patients with dilatation of the aortic root
and ascending aorta, however, commonly have concomitant
cusp pathology that requires treatment.3,4 Furthermore,
aortic insufficiency (AI) may occur in the absence of aortic
pathology as a result of primary cusp disease.5 Repair
techniques for the aortic valve, particularly for cusp pathol-
ogy, remain heterogeneously and infrequently applied and
have not been systemically characterized. A major limitation
to the more generalized application of aortic valve repair
techniques is the absence of a common framework for valve
assessment to guide the approach to valve repair.
Important lessons in this regard may be learned from the
development of mitral valve repair. The Carpentier classifi-
cation6 of mitral valve insufficiency was responsible, in large
part, for the development and generalized dissemination of
repair techniques for the mitral valve, because it provided
a common language for cardiologists, anesthesiologists,
and surgeons to communicate about disease mechanisms
and pathology. Key characteristics of that classification sys-
tem were that it encompassed the entire spectrum of disease,
it clarified and provided insight into the mechanism of in-
sufficiency, it could be consistently applied with different
assessment modalities (echocardiography and surgical as-
sessment), it guided the repair techniques, and, finally, it pro-
vided a framework for the assessment of long-term outcome
for differing mitral valve pathologic entities.
During the past decade, we have developed a similar clas-
sification of aortic valve insufficiency with these character-
istics in mind.7 The purpose of this study was to describe
our experience with aortic valve repair for AI according to
this systematic approach and to evaluate this classification
system specifically with respect to its ability to guide surgi-
cal repair and predict clinical outcome.
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AI ¼ aortic insufficiency
STJ ¼ sinotubular junction
VAJ ¼ ventriculoaortic junction
MATERIALS AND METHODS
Patient Population
From December 1995 to March 2007, a total of 264 consecutive patients
referred for nonemergency surgery with at least 2þaortic valve insufficiency
underwent surgical procedures on the aortic valve, aortic root, and ascend-
ing aorta at a single center. These patients comprise the study cohort. Spe-
cifically, patients with type A aortic dissection were excluded. Data on
surgical techniques and classification of AI were collected prospectively
and analyzed retrospectively. The choice of surgical technique was entirely
at the surgeon’s discretion. Patients undergoing concomitant cardiac proce-
dures were included.
Classification of AI
During a similar period, a classification system for AI according to mech-
anisms of disease and the repair techniques used was developed and applied
to this patient population (Figure 1).7 This classification centers around the
idea that the aortic valve, much like the mitral valve, consists of two major
components, the aortic annulus and the valve leaflets. Unlike that of the mi-
tral valve, however, the annulus of the aortic valve is not a single anatomic
structure. The functional aortic annulus rather consists of two separate com-
ponents, the ventriculoaortic junction (VAJ) and the sinotubular junction
(STJ). As in the Carpentier classification of mitral valve disease, regurgita-
tion associated with normal leaflet motion is designated as type I. Type I AI
is largely due to lesions of the functional aortic annulus, with type 1a AI
resulting from STJ enlargement and dilatation of the ascending aorta, type
Ib resulting from dilatation of the sinuses of Valsalva and the STJ, type Ic
resulting from dilatation of the VAJ, and type 1d resulting from cusp perfo-
ration without a primary functional aortic annular lesion. Type II AI is due to
leaflet prolapse as a result of excessive cusp tissue or commissural disrup-
tion. Type III AI is due to leaflet restriction, which may be found in bicuspid,
degenerative, or rheumatic valvular disease as a result of calcification, thick-
ening, and fibrosis of the aortic valve leaflets.
Patients may have either single or multiple lesions contributing to their
AI. For example, patients with isolated type Ib AI (from dilatation of the
sinuses of Valsalva) are expected to have a central regurgitant jet. The pres-
ence of a sinus of Valsalva aneurysm with an eccentric AI jet therefore sug-
gests concomitant leaflet prolapse (type II) or restriction (type III). Further
assessment of leaflet anatomy can help to delineate more fully the different
mechanisms contributing to AI.
Surgical Techniques
Intraoperative transesophageal echocardiography was routinely per-
formed. All procedures were performed through a median sternotomy.
The ascending aorta or proximal aortic arch was cannulated, along with
either single, two-stage right atrial cannulation or bicaval venous cannula-
tion, depending on the concomitant procedures being performed. After sys-
temic heparinization, the aorta was crossclamped, and antegrade warm,
blood cardioplegia was administered either through the aortic root or
through direct coronary ostial cannulation after aortotomy. A transverse aor-
totomy was performed approximately 1 cm above the STJ, and three 4-0
polypropylene sutures were placed at the level of the commissures for expo-
sure. The aortic valve was assessed for the mechanisms of AI, and the echo-
cardiographic findings were corroborated.
Similar to those for the mitral valve, aortic valve repair techniques follow
the broad principle of correcting the lesion identified according to the classi-
fication. In cases of leaflet repair, a functional aortic annuloplasty is added to
stabilize the repair. Annuloplasty to the functional aortic annulus has to be
performed both proximally (VAJ) and distally (STJ) and may be performed
with or without an aortic prosthesis. At the VAJ, annuloplasty may be
accomplished by a valve-sparing root replacement procedure (eg, aortic
valve reimplantation) or by performing subcommissural annuloplasty. Of
note, an aortic valve remodeling procedure requires subcommissural annulo-
plasty for proximal annular stabilization. Subcommissural annuloplasty is
performed to stabilize the VAJ and reduce the width of the interleaflet trian-
gle, as previously described elsewhere,5 with 2-0 pledgeted valve sutures.
Annuloplasty at the STJ may be performed with a Dacron polyester fabric
aortic tube graft of the appropriate diameter or by placing plication sutures
at the STJ. For type II lesions, leaflet prolapse can be corrected with a variety
of previously described techniques, including triangular resection (with or
without pericardial patch repair), leaflet plication, and free margin
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FIGURE 1. Repair-oriented functional classification of aortic insufficiency (AI) with description of disease mechanisms and repair techniques used. FAA,
Functional aortic annulus; STJ, sinotubular junction; SCA, subcommissural annuloplasty.
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fication of leaflets is required, with or without patching. The specific tech-
niques recommended to address the mechanism for each class of AI are
indicated in Figure 1. For each lesion type, the primary repair technique ad-
dresses the mechanism of the regurgitant lesion and the secondary technique
typically involves stabilization of annulus through annuloplasty of the func-
tional aortic annulus. In some cases, adjunctive repair techniques are used for
intraoperatively discovered pathologic entities, not adequately diagnosed on
preoperative echocardiography or for induced leaflet pathologic problems,
such as induced leaflet prolapse after a valve-sparing root replacement
procedure.
After the completion of repair, transesophageal echocardiography is crit-
ical for valve assessment. It was therefore performed in all patients specif-
ically to assess the degree of AI, the orientation of the regurgitant jet (if
present), and the coaptation length and coaptation level of the aortic valve
cusps. Coaptation length of at least 5 mm at the midportion of the free mar-
gin and a coaptation level above the aortic valve annulus was a prerequisite
for a successful repair, and the presence of an eccentric residual AI jet was
an indication for reexploration of the aortic valve.
Postoperative Care
All patients were treated with aspirin after the operation and underwent
transthoracic echocardiography before discharge.
Follow-up
Clinical follow-up was conducted either through outpatient visits or as
telephone follow-up conducted by a research nurse. In addition to survival
status, information on valve-related complications including thromboembo-
lism, hemorrhage, endocarditis, reoperation, and cardiovascular symptoms
was obtained whenever possible. Transthoracic echocardiography was per-
formed for all patients after discharge and at regular intervals during the
course of follow-up. Echocardiograms not obtained at our institution were
interpreted by the referring cardiologist.
Statistical Analysis
Data are presented as mean  SEM for continuous data or as median
with interquartile range for nonparametric data. Failure time data for
survival, reoperation, and recurrent AI are presented with Kaplan–Meier
survival curves. Comparisons between groups for failure time data were
performed with the log-rank test. Statistical analyses were performed with
SAS version 9.1 software (SAS Institute, Inc, Cary, NC). Graphs were
constructed with GraphPad Prism 4.0 (GraphPad Software, Inc, San Diego,
Calif).
RESULTS
Patient Population
A total of 264 patients with significant AI (2þ) under-
went aortic valve repair with or without aortic root, ascend-
ing aortic and concomitant cardiac procedures. Table 1
depicts the preoperative characteristics of study patients.
The mean age was 54  16 years, with about 80% of pa-
tients being male. More than 70% of patients had symptoms
(New York Heart Association functional class II), and
TABLE 1. Preoperative data
Age (y, median and range) 55 (11–85)
Male sex (No.) 209 (79%)
New York Heart Association functional class (No.)
I 76 (29%)
II 130 (49%)
III 56 (21%)
IV 2 (1%)
Previous cardiac surgery (No.) 18 (7%)
Left ventricular ejection fraction (No.)
>50% 228 (86%)
30%–50% 33 (13%)
<30% 3 (1%)
Left ventricular end-systolic diameter
(mm, mean  SEM)
41  10
Left ventricular end-diastolic diameter
(mm, mean  SEM)
60  9
Aortic insufficiency grade (No.)
I 0 (0%)
II 67 (25%)
III 153 (58%)
IV 44 (17%)
Indication for surgery (No.)
Aortic insufficiency 113 (43%)
Aortic insufficiency plus aortic dilatation 151 (57%)
Aortic diameter (mm, mean  SEM) 53  9
Etiology (No.)
Degenerative 147 (56%)
Bicuspid 90 (34%)
Marfan syndrome 10 (4%)
Endocarditis 9 (3%)
Other (rheumatic, aortitis, trauma, fibroelastoma) 10 (4%)
TABLE 2. Operative and postoperative data
Cardiopulmonary bypass time (min, mean  SEM) 114  5
Cardiac ischemic time (min) 87  5
Aortic valve anatomy (No.)
Tricuspid 171 (65%)
Bicuspid 90 (34%)
Quadricuspid 3 (1%)
Concomitant procedures (No.) 85 (32%)
Mitral valve repair 41 (16%)
Mitral valve replacement 2 (1%)
Tricuspid valve repair 11 (4%)
Coronary artery bypass grafting 34 (13%)
Aortic arch procedures 7 (3%)
Other (left ventricular aneurysm, atrial ablation,
patent foramen ovale closure, myxoma)
12 (5%)
Postbypass transesophageal echocardiography (No.)
No aortic insufficiency 171 (65%)
Grade I aortic insufficiency 8 (30%)
Grade II aortic insufficiency 12 (5%)
Repeat cardiopulmonary bypass for repair of residual
aortic insufficiency (No.)
14 (5%)
Death (No.) 3 (1%)
Stroke (No.) 1 (0.4%)
Reoperation for bleeding or infection (No.) 12 (5%)
Need for pacemaker (No.) 6 (2%)
Hospital stay (d, median and range) 6 (5–7)
Discharge echocardiography (No.)
No aortic insufficiency 73 (28%)
Grade I aortic insufficiency 163 (63%)
Grade II aortic insufficiency 21 (8%)
Grade III aortic insufficiency 1 (0.4%)
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common etiology of AI was degenerative, followed by bi-
cuspid aortic valve, Marfan syndrome, and endocarditis.
For 43% of patients, the AI was the primary indication for
surgery. For the remaining 53% of patients, who had both
aortic dilatation and AI, the mean maximal aortic diameter
was 53  9 mm.
Intraoperative and postoperative data are presented in
Table 2. The cusp anatomy was tricuspid in 65%, bicuspid
in 34%, and quadricuspid in 1%. Postrepair intraoperative
transesophageal echocardiography revealed AI grade II in
12 patients (4.5%). This prevalence was increased to 21 pa-
tients (8%) on discharge echocardiography. In-hospital
mortality was 1.1% (n¼ 3). Causes were multiorgan failure
(n ¼ 1), respiratory failure (n ¼ 1), and congestive heart
failure (n¼ 1). One patient had a stroke. Six patients under-
went aortic valve reoperation during the index admission. In
3 of these cases, the valve was repaired again; the other 3
patients underwent aortic valve replacement. Of the patients
who underwent another repair, 1 had an aorta–right ventric-
ular fistula caused by tearing of the membranous septum by
the subcommissural annuloplasty suture, and the other 2
had dehiscence of leaflet suture lines (1 direct suture of re-
sected raphe and 1 valve patch). Of the patients who under-
went aortic valve replacement, 1 had recurrent leaflet
prolapse and 2 had significant recurrent AI caused by
a lack of central coaptation. There were no deaths among
patients undergoing aortic valve reoperation during the in-
dex admission.
Classification of AI
The classification of AI in the study cohort is presented
in Figure 2. A total of 376 lesions were diagnosed in 264
patients. Approximately two thirds of patients were found
to have solitary lesions. Two lesions were identified in
30% of patients and three in 6%. Fifty percent of lesions
were type I (normal leaflet motion with functional aortic an-
nular dilatation or cusp perforation), 35% were type II
(leaflet prolapse), and 15% were type III (leaflet restric-
tion). The most common sets of multiple lesions were
prolapse of aortic valve leaflet in combination with type
Ia (STJ dilatation, n ¼ 14) or type Ib (aortic root aneurysm,
n ¼ 38) disease.
Prediction of Surgical Techniques
The ability of the classification system to predict the sur-
gical technique used was evaluated by retrospectively com-
paring the predicted surgical technique with the actual
technique used. For example, for isolated type Ia disease
caused by STJ dilatation and ascending aortic aneurysm,
the classification predicts STJ annuloplasty (typically with
an aortic prosthesis), with subcommissural annuloplasty to
stabilize the VAJ. We found that 100% of patients under-
went STJ remodeling, and 82% underwent subcommissural
annuloplasty. Similar predictability results for the other
classifications are presented in Table 3. In addition to the
predicted necessary corrective techniques, adjunctive tech-
niques were also used in some cases to correct intraopera-
tively discovered pathology. For example, in type Ia
disease, leaflet shaving (n ¼ 1) and quadricuspid leaflet re-
pair (n ¼ 1) were performed. The types and frequencies of
adjunctive techniques used are also presented in Table 3.
Overall, patients underwent surgical repair as predicted by
the AI classification in 82% to 100% of cases, and adjunc-
tive repair techniques were used in 4% to 35% of cases. The
ability of the classification to predict the surgical technique
Two Lesions (n = 80)
Type Ib and II 38 (48%)
Type Ia and II 14 (18%)
Type Ib and III 10 (12%)
Type II and III 10 (12%)
Type Ia and III 3 (4%)
Type Ic and III 2 (3%)
Type Id and II 2 (3%)
Type Ib and Id 1 (1%)
Three Lesions (n = 16)
Type Ib, II, and III 11 (69%)
Type Ia, II, and III 3 (19%)
Type Ib, Id, and II 1 (6%)
Type Id, II, and III 1 (6%)
One
64%
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30%
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Lesion Number
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FIGURE 2. Description of aortic valve pathology according to number of lesions (top left), types of pathology observed (bottom left), and description and
frequencies of multiple pathologies observed (right).
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Predicted technique Adjunct techniques
Class Description Actual use Description Frequency
One lesion
Ia (n ¼ 22) STJ remodeling, SC annuloplasty 100%; 82% Leaflet shaving, quadricuspid repair 4%, 4%
Ib (n ¼ 50) AV-sparing procedures 100% Leaflet repair: bicuspid, tricuspid 12%, 10%
Ic (n ¼ 21) SC annuloplasty 100% Leaflet repair 29%
Id (n ¼ 6) Patch repair, SC annuloplasty 100%, 83% STJ plication 17%
II (n ¼ 54) Leaflet repair, SC annuloplasty 100%, 91% STJ plication 31%
III (n ¼ 17) Leaflet repair, SC annuloplasty 100%, 82% STJ plication 35%
Two lesions
Ia and II (n ¼ 14) STJ remodeling, SC annuloplasty, leaflet repair 100%, 93%, 100% — —
Ib and II (n ¼ 38) AV-sparing procedures, leaflet repair 100%, 100% Leaflet shaving 5%
Ib and III (n ¼ 10) AV-sparing procedures, leaflet repair 100%, 90% STJ plication 10%
II and III (n ¼ 10) Leaflet repair, SC annuloplasty 100%, 100% STJ plication 30%
Three lesions
Ib, II, and III (n ¼ 11) AV-sparing procedures, leaflet repair 100%, 100% — —
STJ, Sinotubular junction; SC, subcommissural; AV, aortic valve.was evident for patients with one, two, or three concomitant
lesions.
Clinical Outcome
Clinical follow-up was complete for 99% of patients,
1171 patient-years, with a median follow-up of 47 (inter-
quartile range 29–73) months. Echocardiographic follow-
up was complete for 95% of patients. Midterm clinical
outcomes for the entire cohort are depicted in Figure 3.
Overall survivals were 95%  3% at 5 years and 87% 
8% at 8 years. Freedoms from cardiac death were 97% 
3% at 5 years and 95%  5% at 8 years. Freedoms from
aortic valve reoperation at 5 and 8 years were 92%  4%
and 91%  5%, respectively, and freedoms from aortic
valve replacement at 5 and 8 years were 94  3% and
93  4%, respectively. Early complications among the pa-
tients undergoing aortic valve reoperation included 1 death,
1 postoperative myocardial infarction, and 1 reexploration
for postoperative bleeding. Freedoms from AI greater than
2þwere 88%  3% at 5 years and 79%  11% at 8 years.
During the follow-up period, 4 patients had strokes, 1 had
a transient ischemic attack, and 1 had aortic valve endocarditis.
0 12 24 36 48 60 72 84 96
10
30
50
70
90
AV replacement
AV reoperation
Months
%
0 24 48 72 96 120
0
20
40
60
80
100
228 181 147 102 75 53 40 33214 127  96 33 13
Cardiac deaths
All deaths
Months
%
A B
0 12 24 36 48 60 72 84 96
0
20
40
60
80
100
Months
%
195 149 114 79 52 37 26 14
C
FIGURE 3. Clinical outcomes in entire cohort (n¼ 264). A, Overall survival and freedom from cardiac death. B, Freedom from aortic valve (AV) reoperation
and replacement. C, Freedom from recurrent aortic insufficiency greater than 2þ.
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by classification of AI, we compared outcomes among the
different classes of AI. At 5-year follow-up, freedoms
from aortic valve reoperation were similar in types I and II
and slightly reduced in type III (type I or II 94%  4%,
type III 88%  9%, P ¼ .08). Freedom from recurrent AI
(>2þ), however, was significantly lower for type III AI
(restrictive cusp motion) than for type I or II (hazard ratio
2.6, 95% confidence interval 1.1–11.6, P¼ .03). Cusp anat-
omy (ie, number of aortic valve cusps) did not have an
impact on midterm clinical outcome (P ¼ .7; Figure 4).
DISCUSSION
Aortic valve repair techniques are infrequently used for
the correction of AI. This is partly because of the inability
to assess the mechanism of insufficiency systematically
and apply appropriate and reproducible techniques to repair
the valve. By incorporating important lessons from the Car-
pentier classification of mitral insufficiency, we have devel-
oped a repair-oriented classification of AI. During the past
decade, we applied this systematic approach to aortic valve
repair in 264 consecutive patients presenting with AI greater
than 2þ. We found that early and midterm outcomes of aortic
valve repair in this patient population were acceptable, with
95% freedom from cardiac mortality, 91% freedom from
aortic valve reoperation at 8 years, and 88% freedom from
recurrent AI at 5 years. Furthermore, we have demonstrated
that this classification is a useful tool to describe the mech-anism of AI and can predict the repair techniques required
in most cases. Finally, this classification also predicts clini-
cal outcome, with type III AI caused by cusp restriction
being a risk factor for recurrent AI at midterm follow-up.
In summary, this repair-oriented functional classification
of AI can help to increase the application of valve repair
techniques for AI.
Classification of disease mechanisms can aid in the treat-
ment of disease. In the case of AI, our classification system
has successfully provided a common language for use
among cardiologists, anesthesiologists, and surgeons in the
description of AI and its mechanisms. We have previously
demonstrated that there is excellent correlation between
echocardiographic and surgical assessments of the aortic
valve with respect to disease classification.8 Furthermore,
this classification can be used to guide the repair techniques,
thus standardizing the approach to the surgical repair of AI.
In our cohort, we found that the vast majority of patients
with either single or multiple lesions underwent repair
with the techniques predicted by our disease classification.
Adjunctive techniques not predicted by the classification,
however, were used for as many as 35% of patients on the
basis of intraoperative findings. The most common adjunc-
tive techniques were the addition of leaflet repair in type
Ic disease and the addition of STJ plication in type II and
type III disease. The addition of leaflet repair in primary
functional aortic annular disease (eg, type Ic) likely reflects
the intraoperative discovery of previously missed leaflet pa-
thology or induced leaflet prolapse after reduction of0 12 24 36 48 60 72 84
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FIGURE 4. Comparative clinical outcomes of type I or II versus type III aortic insufficiency with respect to freedom from aortic valve reoperation (A, P ¼
.08) and recurrence of aortic insufficiency greater than 2þ(B). Asterisk indicates P¼ .03. C, Comparison of aortic insufficiency recurrence in bicuspid versus
tricuspid aortic valve repair (P ¼ .7).
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of type II and III disease cases, is consistent with the notion of
the two separate components of the functional aortic annulus,
the VAJ and the STJ, that need to be stabilized during aortic
valve repair. Overall, these findings reinforce the idea that al-
though the key aspects of aortic valve repair can be systemat-
ically predicted by using this classification system, important
roles still remain for intraoperative valve assessment and sub-
jective decision making by the operating surgeon.
An important feature of a disease classification is the
prognostic information it provides to optimize patient selec-
tion and guide treatment. In our experience, type III AI,
caused by cusp restriction, was predictive of midterm AI
recurrence. Although reoperation rates were not signifi-
cantly different, this information is an important factor to in-
corporate into the decision making regarding repair versus
replacement of the aortic valve. Interestingly, cusp anatomy
(ie, number of cusps) had no impact on midterm clinical or
echocardiographic outcome. Classification of AI also pro-
vides the ability to compare midterm and long-term clinical
outcomes of different repair techniques in a comparable
group of patients.
Other classification systems have been proposed for aortic
valve disease. Haydar and colleagues9 presented a classifica-
tion system that they applied to 44 patients with AI. Their
cohort consisted primarily of young patients (mean age 33
years), with most having congenital aortic valve disease
(68%). Although they classified AI into three types (caused
by annular dilatation, redundant leaflet tissue, and deficient
leaflet tissue), they did not specifically classify patients
with aortic root and ascending aortic pathology, which is
a common cause of AI in adults, or those with cusp perfora-
tion or rupture of fenestrations. Lansac and associates10 re-
cently reported a detailed classification system for AI that
was based on postmortem assessment. Their proposed sys-
tem provides limited information regarding reparability,
however, because valve-sparing surgery was performed in
fewer than 10% of their cases, and the degree of AI in that
population was not reported. Furthermore, no specific corre-
lations between echocardiographic and pathologic findings
were reported. Finally, Sievers and colleagues11 have de-
scribed a detailed anatomic classification of bicuspid aortic
valves according to pathologic examination; this provides
useful anatomic information but is not specifically geared to-
ward repair techniques. In contrast, our classification both
successfully encompasses all anatomic subsets of AI and
provides insight into mechanisms and surgical treatment.
Aortic valve repair has numerous potential advantages
relative to prosthetic valve replacement. First, it preserves
the dynamic native aortic valve annulus and native valve
tissue, which may have hemodynamic benefits relative to
a rigid prosthetic valve stent. Second, avoidance of a me-
chanical prosthesis, which would often be used in this young
population, reduces the risk of thromboembolic and antico-
agulation-related complications. Finally, valve repair has
been proposed to carry a low incidence of valve endocardi-
tis.12 In 1171 years of patient follow-up, we saw only 1 case
of endocarditis, which corresponds to a linearized rate of
0.08% per patient-year. Furthermore, only 5 patients in
our cohort had events that could be attributed to thromboem-
bolism, yielding a linearized rate of 0.43% per patient-year,
which is approximately half the rate reported for prosthetic
aortic valves.13,14 The risk of reoperation for disease recur-
rence is perhaps the most important factor when comparing
repair with bioprosthetic valve replacement. In our experi-
ence, the risk of aortic valve reoperation was acceptable
for this young cohort of patients, with a freedom from reop-
eration of 91% at 8 years overall. For patients with type I or
II disease, the freedom from reoperation was 94% at 8 years.
Similar results have been reported by others in contemporary
literature .12,15 It is important to note in this context that rates
of modern bioprosthetic structural valve deterioration are
significantly higher among younger patients (3.7%/year in
patients younger than 50 years and about 2%/year in pa-
tients between 50 and 60 years old).16 It is likely that increas-
ing experience with valve repair techniques, as well as
optimal patient selection, will help to improve the durability
of aortic valve repair. Finally, an aortic valve reoperation
after repair is theoretically simpler from a technical perspec-
tive than one after placement of a stented or stentless
prosthesis. Ultimately, the decision to propose aortic valve
repair versus replacement needs to incorporate numerous
patient- and disease-specific factors, patient preferences,
and the surgeon’s experience. Longer-term follow-up data
will help to guide this decision making, particularly for
younger patients with aortic valve disease.
CONCLUSIONS
Aortic valve repair can be performed safely and with ac-
ceptable early and midterm outcomes for patients with AI.
Our proposed classification system encompasses all types
of AI, provides a common language for communication
across different disciplines, guides the repair techniques
used, and can help to predict midterm outcome. Type III
AI, caused by cusp restriction, is a risk factor for recurrent
AI. This systematic, repair-oriented functional classification
can help to increase the use of repair techniques for AI.
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Discussion
Dr Hans-H. Sievers (Lu¨beck, Germany). First, I must disclose
my financial relationship to the companies of Sorin (Italy) and Aes-
culap (Germany).
Dr El Khoury, I congratulate you on an outstanding study and
especially for your great efforts to promote aortic valve reconstruc-
tion, which is an appealing operation improving in results and tech-
niques. Nevertheless, some results are suboptimal, and a lot of
questions are open. You could nicely demonstrate that a seemingly
simple repair-oriented classification system of AI supports the un-
derstanding of functional anatomy for standardization of recon-
structive techniques. Also, your classification system, which
combines surgery and anatomy, is useful to direct the choice of
the operative method in general. More details, however, are impor-
tant for decision making and the success of the operation. Briefly,
precise definitions are desirable. Thus my first question is as fol-
lows. Your classification type I refers to dilatation of different
levels of the root. What exactly do you mean by dilatation? You
measured the diameters by echocardiography and intraoperatively,
but what are your threshold values for diameters to call it dilatation,
which is important for decision making?
Dr El Khoury. Thank you, Dr Sievers. The concept of func-
tional aortic annular dilatation is helpful in determining the surgical
techniques for this strategy. When we have functional aortic annu-
lar dilatation, we have aortic regurgitation; conversely, when we
have aortic regurgitation, I believe we have some kind of functional
aortic annular dilatation. Saying that, type Ia and type Ib are the
classic aneurysmal dilatation of the aneurysmal descending aorta
and the root, and we use the standard measurement as the indication
for surgery. If we look at types Ic, Id, and even II, I support that
there is functional aortic annular dilatation. We have to look at it
as a mismatch between the quantity of leaflet present and the aortic
orifice. So the idea is that when we have this mismatch between the
quantity of tissue and the orifice, we have two ways to restore
the match: either extend the leaflet with cusp extension, or reduce
the functional aortic annulus. So for types Ia and Ib, it is the classic
definition of aneurysm, but for types Ic, Id, and II, it is really the
idea that when we have regurgitation, we have some kind of mis-
match, and the idea of valve repair is to restore the match between
the leaflet and the aortic orifice.
Dr Sievers. Second, when you assess the aortic valve for the
mechanisms of AI, especially in type II insufficiency, do you use
special tricks or instruments or sutures to imitate the shape of the
root at diastolic pressure to decide which of the various techniques
to apply?
Dr El Khoury. After the standard transverse aortotomy, I use
a systematic approach. After the transverse aortotomy 1 cm above
the STJ, I put three-sutures at the commissures, and I put traction on
those three sutures. First, I inspect, and sometimes in the first in-
spection I can see which leaflet is prolapsing or if the three leaflets
are at the same level. So, the first step is inspection. If I am not
happy with the inspection, I have to know the appropriate level
of the leaflet. If one looks at the normal aortic valve in an echocar-
diogram, if this is the STJ and this is the leaflet, if one looks at the
echocardiogram, the level of the free margin is really at the mid
height of the commissure or mid height of the sinus of Valsalva.
So when I open the aorta, I put traction on the three commissures,
and with the forceps at the middle of the Arantius node, I can push
down the leaflet and see at which level each leaflet goes down and
whether the three leaflets are at the same level. This is one way I
use.
The second way I use is to put a 7-0 or 8-0 suture at the middle of
the cusps and pull up. Usually the free margins are running parallel
when the leaflets are normal, but if one looks on the prolapsing one,
the free margin is not parallel. So the nonparallel free margin is the
prolapsing one. I don’t use any instruments.
Dr Sievers. The last question is as follows. I had to reoperate on
some of our 430 reconstructed aortic valves for subcommissural an-
nuloplasty failure, but only in patients with a bicuspid valve, not
a tricuspid. So at least in my hands, there seems to be a difference
concerning subcommissural annuloplasty and valve etiology. Do
you think it makes sense to consider valve etiology in your re-
pair-oriented classification system?
Dr El Khoury.We were taught by Professor Carpentier that car-
diac surgeons usually don’t care about etiology. We have to restore
the function of the valve.
The bicuspid aortic valve in our classification is type II or type I.
So it can be type Ia, Ib, or whatever. This is mainly Ia and Ib, and I
think that it is Ic in the pediatric population. I am aware of your clas-
sification for bicuspid aortic valve. And we had a discussion in New
York at the Aortic Symposium about the indication for surgery and
the size of the aortic root and bicuspid, tricuspid, whatever. But I
think we have missed one thing, that is the perioperative assessment
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Dbicuspid aortic valve, even if the aortic root is normal, we can find
that the leaflet at the insertion to the aortic wall is too transparent,
too thin, and we can see even the muscle. So in those cases, I think
we have to be more aggressive and not do subcommissural annulo-
plasty but go to the valve-sparing operation, the David operation or
whatever. I think that diameter is not enough for the indication to
replace the ascending aorta with a bicuspid aortic valve. We also
have to look the quality of the tissue.
Dr Christopher M. Feindel (Toronto, Ontario, Canada). First,
I congratulate you for trying to put some methodology and organi-
zation to what still seems to be an eyeballing technique. I think this
is a great help.
I do have a question about type III and your efforts to decalcify
valves. I must say, years ago I learned painfully that this was a lousy
operation, and we ended up reoperating on every one of those pa-
tients.
Dr El Khoury. With regard to type III, we have two kinds. We
have type III associated with bicuspid aortic valve when we have
the raphe, so we can resect the raphe. This is one thing. Type III
with a tricuspid aortic valve, however, in our experience is differ-
ent. I repaired everything some years ago, but now I really limit
in type III when I see, for instance, coronary artery surgery and
moderate aortic regurgitation and moderate stenosis. The valve re-
ally doesn’t move very well, so in those patients we replace or re-
pair the valve. In many, many of those patients, really almost all the
patients, we go and do some shaving, clean the valve, and add sub-
commissural annuloplasty.
Dr Feindel. And do you not think that those patients come back
faster for reoperation but now with, in many cases, working bypass
grafts?
Dr El Khoury. I am not sure that we are accelerating the pro-
cess. You can do nothing, and maybe the patient will come back
for repair the valve. I am not sure that we are really accelerating
the process of calcification by only shaving.
Dr Feindel. Our experience has been different. We have found
that we ended up reoperating on those patients 3, 4, 5 years down
the road, whereas with a bioprosthetic valve, the patient has at least
10, 12, or 15 years.
Dr El Khoury. It would be useful to conduct a randomized
study.294 The Journal of Thoracic and Cardiovascular Surgery c February 2009
